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B100085 AtrialStunningOccuraafterElectricalCardlovarelon,butnotAfterChemical
Cardloveraion
J.M. Aranda, J. Tauth, J. Brewington, M. Lockeby, H. Fontanet. Div. of
Cerdiol~, Univ.of SouthFlorida,andtheJamesA. HaleyVAMC,Tamps,
FL,USA
Delayed recovery of atrial mechanical func4ionafter electrical csrdioversion
ia well documented. However, the time frame of recovety of atrial mechan-
ics after chemical cardioveraion is not well known. Thus, we prospectively
studied 40 consecutive patients who underwent either chemical (CC n = 24)
or electrical cardioversion (EC n = 16) for atrial fibrillation and determined
the time to returnof atrial mechanical function. Transmittal inflow Doppler
measurement of velocity time integral (~lT), E wave VTIE, and A wave VTIA
were measured at baseline, 24hrs., 1week and 2 weeks after cerdioversion.
Baseline measurements of LA diameter, LA area, and EF, were performed
by 2D echo. Resslts:There wereno differences in the baseline LA diameter
(4.3+0.5 cm vs. 4.5+0.5cm), Uarea (17.2 + 3.4cm2 vs. 16.9+ 3.5cm2),
or EF (51 + 10 vs. 52 + 8Yo) I@veen CC and EC, respectively. However,
CC patients demonstrated earlier recovery of atrial function wiA > 25% of
mitral flow) comparedto EC patients (see graph).
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CorrdusiomChemical but not electrical cerdioversion of atrial fibrillation
results in early return (< 24 hrs.) of atrial mechanical activity. Whether CC
may be associated with lower incidence of embolic phenomena es compared
to electrical cerdiovereion requires further investigation.
m100086 ThaRataandVariabilityof FibrillatoryActivityPredictPersistenceofAtrialFibrillation(AF)in
Humana
N.K. Kanuru, A. Bollmann, J.D. Neff, J.J. Lsngberg. EmoryLAriversifyand
GeorgiaInstituteof Tachnolog~Atlanta,GA,USA
Experimental atudies have shown a clear mrrelation between atria! wave-
length, the average frequency of fibrfllatory activity and the persistence of
AF. We hypothesized that rapid and disorganized fibrillatoy activity would
predict persistence of AF in humana. Thirteen episodes of AF were induced
with rapid atrial pacing in 11pts undergoing elactrophysiologic study (8 men,
mean age 56 + 22 years). Bipeiar remrdings from the high right atrium
(bandpass 30-500 Hz) were digitized and fibrillatory waves were quantified
using a peak detection algorithm. Fibrillatory rate was measured as a run-
ning average of 10 cycles over 1 minute after AF onset. The variability of
fibrfllatory activity was quantified as being within the 95% confidence interval
(Cl). These data were compared for 7 episodes of AF that terminated spon-
taneously after 40 + 23 seconds vs 4 episodes that persisted and required
cerdioveraion. The mean fibrillatory cycle length was shorter (151 + 17 msec
vs 196+ 17 msec, p =0.004) and the 95% Cl smaller (62 msec vs 100 msec,
P = 0.022) for OPiSOdOSthat persisted.
Cone/usions:Rapid anddisorganizsd atrial activation predicts persistence
of AF and auggeats that atrial wavelength is an important determinant ofAF
severity in humans.
m100087 SponteneouaReinitiationofAtrialFibrillationFollowingTranavenouaAtrialDefibrillation
C. Narasimhan, J. Sra, Z. Blanck, A. Dhala, M. Biehl, S. Deshpande,
M.R. Jazsyeri, M. Akhtar. St.Luke%MadicslCenterMilwaukee,W, USA
Lowenergy transvenous atrial defibrillation has been very effective in reator-
ing sinus rhythm. The frequency ofspontansous reinitiation of atnal fibrillation
(AF) ie not known. We obsetved this intriguing phenomenon during transve-
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nous atrial defibrillation which forms the basis for this reporl. The mechanism
of reinitiation of atrial fibrillation after atrial defibrillation has been WOrly
studied as well and could be a significant problem.
Methodsand Reau/ts:Eleven patients (3 male, 8 female, mean age 80
+ 8 yrs) underwent transvenoua atrial defibrillation. Four of the 11 patients
were on antiarrtrythmic therapy at the time of the study. AF was induced by
R wave synchronous shocks or atrial burst pacing. Atrial defibrillation was
performed under anesthesia baiwaen two multipolar catheters introduced
transvenoualy (one in the right atrium and one in the coronary sinus). Of
these 11patients, 7 remained in sinus rhythm and 4 patients had reinitiation
of atriai fibrillation after successful atrial defibrillation. There were 12episodes
of AF that were initiated by premature atrial complexes (PACS).The coupling
interval of the PACSwhich initiated atrial fibrillation was 443 + 43 seconds
(390 to 510 msec). The mean time to reinitiation of AF after cardioversion
was 6.26 + 5.25 seconds. None of the patients on antiarrhythmic agenta nor
those without PACShad reinitiation of AF.
Conclusion:Reinitiation of AF following transvenous atrial defibrillation
occurs in about 30% of patients and is preceded by PACS. The role of
pharmacological or pacing therapy to prevent reinitiation of AF in these
patients needs to be studied.
-~ HemodYna~icchangee~Ur,ngAtrialFibri,iation
andIntactAVNodeConductionComparedto
VentricularPacingat tha SameRate
E.G. Daoud, R. Weiss, B.P. Knight, M. Bahu, W. Paladino, R. Goyal,
K.C. Man, S.A. Strfckberger, F. Morady. Universityof Michiganf-fospita/,Ann
ArboLMl, USA
This study comparsd hemodynamic changes during atrial fibrillation (AF) with
conduction over the AV node-Hia axis vs right ventricular apical pacing at an
identical average rate. In 11pts (8 M; 3 F) (ejection fraction 59 & 8%) referred
for AVjunction radiofrequency ablation (RFA) for AF, the Fick cardiac output
(CO) and pulmonary artery and wedge pressures were measured during
AF with conduction over the AV node at baseline and an isoproterenol
(ISO) infusion. After RFA, hemodynamice were remeasured during AF with
complete AV block and ventricular pacing at the same average rates as
during AF prior to RFA at baseline and during ISO infusion. The pre-RF
ventricular cycle lengths with and without ISO were 434 + 63 and 555 &
102 ms (p < 0.01). In comparison to Pre-RFA wedge pressures, there were
no significant changes in wedge pressure during pacing post-RFA with (11
+ 4 vs 10 + 4 mmHg, p = 0.4) or without ISO (12 * 5 va 12 * 4 mmHg,
p = 0.9). kI COmpSI’iSOnto pre-RFA pulmonary artery pressures, them wera
no significant changes in pulmonary artery pressure during pacing post-RFA
with (20 + 5 vs 21 & 6 mmHg, p = 0.4) or without ISO (20 + 6 vs 22 + 8
mmHg, p = 0.2). The pre- and post-RFA CO’s in the absence of ISO were
3.6 + 0.5 and 3.8 + 0.8 Umin (p = 0.9), and were 4.7 + 0.9 and 4.9 + 1.4
Umin during ISO infusion (p = 0.4).
Conclusion:In pts with AF, a rapid ventricular rate, and no ventricular
dysfunction, there is no difference in hemodynamics during irregular con-
duction over the AV node compared to a regular ventflcular paced rhythm
at an identical average rate. These findings suggest that the improvement
in cardiac performance following RFA of the AV junction and placement of a
pacemaker in pts with AF and normal left ventricular function is attributable
more to a reduction in ventricular rate than to regularization of the rhythm.
m100089 EsmoloiRaduceaAtrialDefibrillationThraaholda:A Randomized,Placebo-ControlledStudy
M. Niebauer, M.K. Chung, D. Holmes, D.R. Van Wagoner, P.Tchou. The
ClevelandClinic,Cleveland,OH,USA
Although esmolol (E), an intravenous ~1-adrenergic blocker, has no other
known antiarrhythmic properties, it has been shown to induce acute conver-
sion of atrial fibrillation (AF) in significantly more patients (46%) compared
to either placebo (11%), digoxin (15%) or verapamil (20%). We sought to
determine if E could be used to facilitate electrical cardioversion and hypoth-
esized that E lowers atrial defibrillation threshold. Mattrods:Sixteen patienta
undergoing cardioversion for AF were randomized to E (500 @kg IV bo-
Ius followed by infusion of 50-300 wg/kg/min to maintain a 220Y0 reduction
in ventricular rate) or an equivalent infusion rate of placebo. Patients were
blinded to the randomization and none had received antiarrhythmic drugs,
fJ-blockers,verspamil, ordiltiazem within 5 half-lives. Transthoracic, damped
sine wave shocks, using anterior-posterior patches, were delivered in step-up
Group N Delivsrsd Energy (J) Psak Current (Amps) Impedance (Ohms)
Placebo 7 259.0& 99.5 36.6* 7.3 73.5+ 1s,2
Esmolol 7 145.3 * 90,1t 27.6 * 7.3t 70,1 * 14.4
tPs 0.05 comparedto placebo.
